Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis A Vaccine in Infants and Young Children
NCT00139113Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Sep 1996
- Primary completion
- Jun 2001
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised trial of Hepatitis A virus vaccine in hepatitis A (HAV) (6 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoint: Concentration of antibody to hepatitis A virus. Started Sep 1996; status: completed.
02
Drugs
Hepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT00139113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139113.